BHVN
Biohaven Ltd.
NYSEHealthcareBiotechnologyUS
Rating:D+
Company Profile
CEO
Vladimir Coric
IPO Date
2022-09-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NYSE
Country
US
Biohaven Ltd.
CEO
Vladimir Coric
IPO Date
2022-09-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NYSE
Country
US
| 68,693 |
| $9.61 |
| 30 Apr 2026 | Heffernan Michael Thomas | director | A-Award | Acquired | 68,693 | $9.61 |
| 30 Apr 2026 | Antonijevic Irina | director | A-Award | Acquired | 68,693 | $9.61 |
| 30 Apr 2026 | CHILDS JOHN W | director | A-Award | Acquired | 68,693 | $9.61 |
| 30 Apr 2026 | HUGIN ROBERT J | director | A-Award | Acquired | 68,693 | $9.61 |
| 30 Apr 2026 | GREGORY JULIA P | director | A-Award | Acquired | 68,693 | $9.61 |
| 19 Mar 2026 | Mehta Kishan | director | G-Gift | Disposed | 17,342 | $0.00 |
| 19 Mar 2026 | Mehta Kishan | director | G-Gift | Acquired | 17,342 | $0.00 |
| 9 Mar 2026 | CHILDS JOHN W | director | P-Purchase | Acquired | 28,400 | $30.43 |